Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
Clinical and Translational Allergyvolume 7, Article number: 11 (2017)
The original article was published in Clinical and Translational Allergy 2017 7:1
Erratum to: Clin Transl Allergy (2017) 7:1 DOI 10.1186/s13601-016-0139-2
Information from the manufacturer of the topical intervention in the GSK2646264 trial outlined in this review  indicates that the half-life of the product has not been established with certainty on the available data.
Kocatürk E, Maurer M, Metz M, Grattan C. Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin Transl Allergy. 2017;7:1.
The online version of the original article can be found under doi:10.1186/s13601-016-0139-2.